PerHum Therapeutics Company
PerHum Therapeutics is a core business of the company is to sublicense the CAB-CAR-T technology in Greater China from F1 Oncology.
Technology:
Regenerative Medicine
Industry:
Biotechnology
Headquarters:
China
Founded Date:
1-1
Register and Claim Ownership